IBD is a chronic and recurrent condition with significant local (intestine) and systemic inflammation, and significant increases in pro-inflammatory cytokines including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 (10). This evidence concerns the gene TNF and inflammatory bowel disease.